Results 151 to 160 of about 60,435,326 (243)

Interleukin-23 Receptor and Interleukin-17 Receptor A: Splice Variants, Isoforms and Their Relationship With Periodontitis-A Systematic Review and Bioinformatic Analysis. [PDF]

J Cell Mol Med
Alarcón-Sánchez MA, Guerrero-Velázquez C, Ortuño-Sahagún D, Lomelí-Martínez SM, Becerra-Ruiz JS, Flores-Fraile J, Heboyan A.   +6 more
europepmc   +1 more source

Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis. [PDF]

Am J Clin Dermatol
Ferreira C, Torres T.
europepmc   +1 more source

Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries. [PDF]

J Clin Med, 2023
Sisto M, Lisi S.
europepmc   +1 more source

Sequential Paradoxical Eczema Following Interleukin-23, Interleukin-17, and Tyrosine Kinase 2 Inhibitors in a Single Psoriasis Patient. [PDF]

J Dermatol
Park S, Jo SJ.
europepmc   +1 more source

Interleukin-23 in lung and airway diseases: from pathogenesis to precision-guided therapeutic targeting. [PDF]

Front Pharmacol
Nayak BB, Rajesh R, Teppan J, Gogg T, Böhm E.   +4 more
europepmc   +1 more source

Suspected oncologic adverse reactions associated with interleukin-23 inhibitors in EudraVigilance: Comparative study and gender distribution. [PDF]

Pharmacol Res Perspect, 2023
Calapai F, Mannucci C, Cardia L, Currò M, Calapai G, Esposito E, Ammendolia I.   +6 more
europepmc   +1 more source

Psychiatric safety of bimekizumab versus interleukin-23 inhibitors in psoriasis: A real-world TriNetX cohort study. [PDF]

JAAD Int
Tolete C, Friedman A, Calderon J, Tjahjono L.   +3 more
europepmc   +1 more source

Distinct roles for interleukin-23 receptor signaling in regulatory T cells in sporadic and inflammation-associated carcinogenesis. [PDF]

Front Oncol, 2023
Jacobse J, Pilat JM, Li J, Brown RE, Kwag A, Buendia MA, Choksi YA, Washington MK, Williams CS, Markham NO, Short SP, Goettel JA.   +11 more
europepmc   +1 more source

Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies

Frontiers in Immunology, 2021
Elisabetta Bianchi, Elisabetta Bianchi, Matteo Vecellio, Matteo Vecellio, Lars Rogge, Lars Rogge   +5 more
doaj   +1 more source

New Interleukin-23 Antagonists' Use in Crohn's Disease. [PDF]

Pharmaceuticals (Basel)
Biskup L, Semeradt J, Rogowska J, Chort W, Durko Ł, Małecka-Wojciesko E.   +5 more
europepmc   +1 more source